MoonLake Immunotherapeutics announces landmark Phase 2
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis First placebo-controlled randomized trial in ...
MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis First placebo-controlled randomized trial in ...
Wednesday 19 July, 2023 The extreme swimmer has set yet another record: Nathalie Pohl swum around the British Channel Island ...
Prof. Matthias Schick, Strickhof und AgroVet-Strickhof, Eschikon, Lindau (CH), Ferdinand Mersch, North Rhine-Westphalia Chamber of Agriculture and Prof. Hamdi Bilgen, ...
ENTERTAINMENT Cirque du Soleil Celebrates 30 Years of Wonder and Amazement in Las Vegas This year, the world-renowned entertainment group ...
adidas re-imagines football jerseys as streetwear in new LFSTLR collection, for fans who want to support their clubs while showing ...
SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary ...
Overall response rate (ORR) of 47% and disease control rate (DCR) of 65% in first line (1L) recurrent/metastatic HNSCC patients ...
MARIETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, proudly marks the culmination of a remarkable 2023 ...
Saturday 22 July, 2023 LONDON CALLING! Pure Evil Gallery, London; 17th August – 10th September Welcome to London ...
Media Release Statistically significant increases of Th1 biomarkers (IFN-gamma, CXCL-10), circulating immune cells (lymphocytes), and RNA levels of immune ...
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.